http://orcid.org/0000-0002-9530-3383
Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Gaurav Singh, Stanislav N Tolkachjov & Aaron S Farberg. (2023) Incorporation of the 40-Gene Expression Profile (40-GEP) Test to Improve Treatment Decisions in High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients: Case Series and Algorithm. Clinical, Cosmetic and Investigational Dermatology 16, pages 925-935.
Read now
Read now
Perry B. Hooper, Aaron S. Farberg, Alison L. Fitzgerald, Jennifer J. Siegel, Briana B. Rackley, Anesh Prasai, Sarah J. Kurley, Matthew S. Goldberg & Graham H. Litchman. (2022) Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients. Cancer Investigation 40:10, pages 911-922.
Read now
Read now
Sherrif F Ibrahim, Julia M Kasprzak, Mary A Hall, Alison L Fitzgerald, Jennifer J Siegel, Sarah J Kurley, Kyle R Covington, Matthew S Goldberg, Aaron S Farberg, Shannon C Trotter, Kenneth Reed, David G Brodland, Shlomo A Koyfman, Ally-Khan Somani, Sarah T Arron & Ashley Wysong. (2022) Enhanced Metastatic Risk Assessment in Cutaneous Squamous Cell Carcinoma with the 40-Gene Expression Profile Test. Future Oncology 18:7, pages 833-847.
Read now
Read now
Articles from other publishers (5)
Ashley Wysong, Ally‐Khan Somani, Sherrif F. Ibrahim, Javier Cañueto, Alison L. Fitzgerald, Jennifer J. Siegel, Anesh Prasai, Matthew S. Goldberg, Aaron S. Farberg, Christie Regula, Anna Bar, Julia Kasprzak, David G. Brodland, Shlomo A. Koyfman & Sarah T. Arron. (2024) Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients. Dermatology and Therapy 14:3, pages 593-612.
Crossref
Crossref
Amit Mittal & Bharat B. Mittal. (2024) Comparative Analysis of US Guidelines for the Management of Cutaneous Squamous Cell and Basal Cell Carcinoma. Journal of Skin Cancer 2024, pages 1-12.
Crossref
Crossref
Razan Masarwy, Shahaf Shilo, Narin Nard Carmel Neiderman, Liyona Kampel, Gilad Horowitz, Nidal Muhanna & Jobran Mansour. (2023) The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis. Cancers 15:9, pages 2456.
Crossref
Crossref
Bo M. Kitrell, Elliot D. Blue, Alfredo SillerJr.Jr., Marissa B. Lobl, Tyler D. Evans, Melodi Javid Whitley & Ashley Wysong. (2023) Gene Expression Profiles in Cutaneous Oncology. Dermatologic Clinics 41:1, pages 89-99.
Crossref
Crossref
Philip R. Cohen & Razelle Kurzrock. (2022) Dermatologic Disease-Directed Targeted Therapy (D3T2): The Application of Biomarker-Based Precision Medicine for the Personalized Treatment of Skin Conditions—Precision Dermatology. Dermatology and Therapy.
Crossref
Crossref